oa South African Family Practice - Once-daily dosage lamivudine another ARV first for Cipla Medpro : press release

Volume 50, Issue 1
  • ISSN : 2078-6190
  • E-ISSN: 2078-6204



In an effort to promote adherence to medication and offer convenience to many people living with HIV / AIDS, local pharmaceutical company Cipla Medpro has released South Africa's first single tablet once-daily dosage of the antiretroviral lamivudine. This 300 mg dosage is as effective as the currently available twice daily dose of lamivudine 150 mg and carries the same safety profile.

Loading full text...

Full text loading...


Article metrics loading...


This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error